Loading...
http://jcps.bjmu.edu.cn

Table of Content

    31 August 2023, Volume 32 Issue 8
    Reviews
    An overview of flavonoids from Sophora flavescens (kushen) with some emphasis on the anticancer properties of kurarinone and sophoraflavanone G
    Eric Wei Chiang Chan, Ying Ki Ng, Hung Tuck Chan, Siu Kuin Wong
    2023, 32(8):  603-615.  DOI: 10.5246/jcps.2023.08.050
    Asbtract ( 151 )   HTML ( 46)   PDF (1967KB) ( 77 )  
    Figures and Tables | References | Related Articles | Metrics

    In this overview, the current knowledge of the constituents of flavonoids isolated from the roots of Sophora flavescens (kushen) is updated. Flavonoids consist of several classes, such as flavanones, flavonols, chalcones, isoflavones, biflavonoids, flavanols, and flavones. The most common compounds are kurarinone (KRN), sophoraflavanone G (SFG), 2?-methoxykurarinone, kuraridine, isoxanthohumol, and formononetin. KRN and SFG are two major flavanones with more vital anticancer properties than other flavonoids. From the literature, the cytotoxic values of KRN and SFG are variable and depend on the type of cancer cells tested. The anticancer activities of these two flavonoids involve different molecular mechanisms. Clinical trials are needed before anticancer drugs from KRN and SFG can be developed.

    Advances in immune-targeted therapy for Graves' ophthalmopathy
    Wen Lv, Ying Fu
    2023, 32(8):  616-625.  DOI: 10.5246/jcps.2023.08.051
    Asbtract ( 112 )   HTML ( 16)   PDF (1545KB) ( 55 )  
    References | Related Articles | Metrics

    Graves’ ophthalmopathy (GO) is an autoimmune disease characterized by lymphocytic infiltration behind the eyes. The pathogenesis of this disease is complex, and although no definitive conclusion has been reached, immune factors are believed to play a significant role. Currently, no specific therapeutic drugs are available for GO. Glucocorticoids are recommended as first-line drugs for patients with moderate-to-severe, active GO, but they have significant side effects, and some patients are intolerant. Immune-targeted drugs offer a new treatment option with great promise for clinical application. Recent in-depth studies of the pathogenesis of GO have led to many clinical trial studies of immune-targeted drugs. This article highlights the research progress of three immune-targeted drugs, namely teprotumumab, rituximab (RTX), and tocilizumab (TCZ), with the aim of providing more therapeutic options for GO patients. It's worth noting that although these immune-targeted drugs have unique application prospects, their clinical application is currently limited due to unclear therapeutic effects or cost issues.

    Original articles
    Discovery of potential xanthine oxidase inhibitors based on virtual screening
    Xiaowei Chi, Qi Li, Yi Zhong, Tong Gong, Chuxiao Yi, Liangren Zhang, Zhenming Liu
    2023, 32(8):  626-635.  DOI: 10.5246/jcps.2023.08.052
    Asbtract ( 170 )   HTML ( 13)   PDF (4606KB) ( 56 )  
    Figures and Tables | References | Related Articles | Metrics

    With the continuous improvement of living standards, the incidence of gout is increasing rapidly, and it is becoming more common among younger individuals. Xanthine oxidase (XO) is a crucial target for treating gout, as inhibiting XO can effectively reduce the production of uric acid in the body and alleviate gout symptoms. In the present study, three potential XO inhibitors were identified through virtual screening and validated using surface plasmon resonance (SPR). Among these inhibitors, floxuridine exhibited the strongest binding activity at 0.35 μM, compared with 0.76 μM for the positive drug allopurinol. Molecular dynamics simulations were conducted to examine the binding pattern of these compounds with XO. It is noteworthy that all three compounds are already approved as marketed drugs and have established safety profiles, indicating their potential as effective XO inhibitors.

    Study on synthesis of naringenin derivatives and cholinesterase inhibitory activity in marine Chinese medicine
    Yuxia Zhu, Lingjian Zhang, Yiming Hu, Weihua Liu, Liping Guan, Lin Lin
    2023, 32(8):  636-644.  DOI: 10.5246/jcps.2023.08.053
    Asbtract ( 114 )   HTML ( 12)   PDF (2089KB) ( 40 )  
    Figures and Tables | References | Related Articles | Metrics

    This paper describes the design and synthesis of a series of chalcone derivatives based on naringenin as the lead compound. The compounds were evaluated for their activities against AChE and BuChE using principles of new drug design. The intermediate benzopyran-3-formaldehyde was synthesized from commercial ortho-hydroxybenzaldehyde and acrolein using K2CO3 as a catalyst. The target compounds were obtained through the Claisen-Schmidt reaction of benzopyran-3-formaldehyde and substituted acetophenone. The inhibitory effects of the chalcone compounds against AChE and BuChE were determined using Ellman’s method. Eight compounds showed certain inhibitory activities against AChE and BuChE, with compound 2d exhibiting higher activity against cholinesterase. Molecular docking studies revealed that 2d had a significant interaction with AChE and BuChE. This study suggested that chalcone compounds, including coumarin, might provide a potential pathway for discovering new anti-AD precursors.

    Steaming-induced conversion of the volatile components for P. ginseng, P. quinquefolius, and P. notoginseng by headspace sampling gas chromatography-mass spectrometry (HS-GC-MS) and untargeted metabolomics analysis
    Huimin Wang, Yuying Zhao, Xiaoyan Xu, Humin Xie, Meiting Jiang, Hongda Wang, Bei Xu, Xiaohang Li, Simiao Wang, Boxue Chen, Feifei Yang, Wenzhi Yang
    2023, 32(8):  645-664.  DOI: 10.5246/jcps.2023.08.054
    Asbtract ( 112 )   HTML ( 7)   PDF (3380KB) ( 54 )  
    Figures and Tables | References | Related Articles | Metrics

    Ginseng is a popular tonic worldwide, and its effects can be enhanced by steaming. Previous studies regarding the steaming of ginseng mainly focus on the contained saponins but are rare on the volatile components. In the present study, we developed headspace sampling gas chromatography-mass spectrometry (HS-GC-MS)-based untargeted metabolomics to holistically characterize the altered volatile components of P. ginseng (PG), P. quinquefolius (PQ), and P. notoginseng (PN) during the process of steaming. Chromatographic separation conditions for GC-MS were optimized, by which the volatile components in both the raw and the steaming-processed products (at 1–10 h) for PG, PQ, and PN were characterized within 38 min on an HP-5MS elastic quartz capillary column. We could characterize 106 volatile components from PG, 106 from PQ, and 105 from PN. Multivariate statistical analysis could depict the transformation trajectory for PG, PQ, and PN induced by steaming at different times. Ultimately, 13, 16, and 14 significantly differential volatile components for the steaming of PG, PQ, and PN were discovered by GC-MS-based untargeted metabolomics analysis. Notably, 3-methyl-1-butanol, 2-pentylfuran, hexanal, caryophyllene, and (?)-aristolene were diagnostic to distinguish the raw and processed products for PG. α-Pinene, 2-pentylfuran, hexanoic acid, 2,3-butanediol, and pyruvic acid could distinguish the raw and processed PQ. Cyperene, furfural, 1-isopropyl-4,7-dimethyl-1,2,3,5,6,8a-hexahydronaphthalene, hydroxyacetone, and 1-pentanol could discriminate the raw and processed products of PN. The established GC-MS approach can be a practical tool to investigate the underlying processing mechanism of traditional Chinese medicine by revealing changes in its volatile components.

    Preparation optimiztion of compound Codonopsis Radix granules and simultaneous determination of its four components
    Jie Yang, Caifang Jing, Shaochuang Li, Sitong Liu, Dongming Li, Qinqing Li, Wenbin He
    2023, 32(8):  665-676.  DOI: 10.5246/jcps.2023.08.055
    Asbtract ( 128 )   HTML ( 4)   PDF (1862KB) ( 28 )  
    Figures and Tables | References | Related Articles | Metrics

    In the present study a single-factor experiment and response surface methodology were utilized to optimize the spray-drying process of compound Codonopsis Radix granules and determine the optimal spray-drying process parameters. The proportions of excipients were examined using indicators of molding rate and moisture absorption rate. High-performance liquid chromatography (HPLC) was established to simultaneously determine the contents of lobetyolin, ferulic acid, calycosin-7-O-β-D-glucoside (CG), and glycyrrhizin in the compound Codonopsis Radix granules. The findings indicated that the highest spray-drying yield was achieved when the inlet temperature of spray drying was set at 145 oC, the inlet air velocity at 75%, the feed rate at 8%, and the drying aid at 5%. A ratio of paste starch to powdered sugar at 2:1 resulted in a good particle molding rate and moisture absorption rate. By effectively optimizing the spray-drying process of compound Codonopsis Radix granules and excipient dosage this study provides a valuable reference for the production and preparation of these granules. The contents of lobetyolin, ferulic acid, glycyrrhizin, and CG in the compound Codonopsis Radix granules were found to be 0.38, 0.22, 0.45, and 0.25 mg/g, respectively. These results provided a foundation for establishing a quality control method for compound Codonopsis Radix granules.

    Case report
    A case of anaphylactic shock caused by iodixanol during transjugular intrahepatic portosystemic shunt and literature analysis
    Weiwei Xie, Jian Liu, Yuqian Zhang, Zhiqing Zhang, Yiran Jin
    2023, 32(8):  677-682.  DOI: 10.5246/jcps.2023.08.056
    Asbtract ( 95 )   HTML ( 3)   PDF (1456KB) ( 26 )  
    References | Related Articles | Metrics

    A 68-year-old patient was admitted to the Department of Gastroenterology at the Second Hospital of Hebei Medical University and underwent a transjugular intrahepatic portosystemic shunt (TIPS) under local anesthesia using iodixanol injection for high pressure imaging. After 15 min, the patient developed symptoms, such as a drop in blood pressure and skin itching, indicating anaphylactic shock. We promptly administered emergency measures, including antiallergic and anti-shock treatment. The patient’s vital signs gradually recovered, and the symptoms of anaphylactic shock disappeared. Ultimately, the operation was successfully completed without any complications. This article analyzed the rescue measures and treatment of a patient who experienced anaphylactic shock due to an iodixanol injection during TIPS. The purpose was to increase awareness of the safe use of iodixanol. When iodixanol is used for contrast, a patient may experience a drop in blood pressure and skin itching within a short period of time, potentially leading to anaphylactic shock. During the operation, it is crucial to closely monitor the patient’s condition and promptly recognize allergic symptoms for effective treatment. This is the key to rescuing a patient experiencing anaphylactic shock.

    News
    The School of Pharmacy successfully hosted the 2023 "Pharmaceutical Preparation Frontier Technology Summit Forum"
    School of Pharmaceutical Sciences, Peking University Health Science Center
    2023, 32(8):  683-685. 
    Asbtract ( 92 )   PDF (4128KB) ( 34 )  
    Related Articles | Metrics
    The School of Pharmacy successfully hosted the 2023 "Pharmaceutical Preparation Frontier Technology Summit Forum".
    Prof. Wanliang Lu was elected as Chairman of the Pharmaceutical Committee of the Chinese Pharmaceutical Society
    School of Pharmaceutical Sciences, Peking University Health Science Center
    2023, 32(8):  686-687. 
    Asbtract ( 91 )   PDF (3541KB) ( 12 )  
    Related Articles | Metrics
    Prof. Wanliang Lu was elected as Chairman of the Pharmaceutical Committee of the Chinese Pharmaceutical Society.
    The research team of Prof. Wanliang Lu has made progress in the study of recombinant virus-like biologics for gene therapy
    State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
    2023, 32(8):  688-690. 
    Asbtract ( 63 )   PDF (3055KB) ( 12 )  
    Related Articles | Metrics
    The research team of Prof. Wanliang Lu has made progress in the study of recombinant virus-like biologics for gene therapy.